However, in cancer cells, the network of feedback signal pathways to NFκB is not intact, leading, on the one hand, to protection of cancer cells from the immune system, and, on the other hand, to destruction of noncancerous tissue [3,4,56]. This evidence concerns the gene NFKB1 and cancer.